CURRICULUM VITAE - Your Medical DetectiveCURRICULUM VITAE Aristo W/Vojdani, Ph.D., M.Sc., C.L.S....

1

CURRICULUM VITAE

Aristo W/Vojdani, Ph.D., M.Sc., C.L.S.

Professor of Neuroimmunology

CITIZENSHIP United States of America

MARITAL STATUS Married with three children

PHONE NUMBERS Work (310) 657-1077

Fax (310) 657-1053

E-mail: [email protected]

EDUCATION

1972-1976 Bar Ilan University, Israel, Ph.D.

Immunology & Microbiology

1970-1972 Bar Ilan University, Israel, M.Sc.

Microbiology & Immunology

1966-1970 Bar Ilan University, Israel, B.S.

Major: Microbiology

Minor: Biochemistry

POSTDOCTORAL TRAINING

1979-1981 Comparative Immunology Research at University

of California, Los Angeles

1976-1977 Cellular Immunology Research at Tel Aviv

University Medical Center, Assaf Harofe Hospital

ACADEMIC POSITIONS

Present Adjunct Associate Professor, Department of Preventive Medicine

Loma Linda University

Adjunct Professor, National University of Health Sciences

Lincoln College of Professional, Graduate and Continuing Education

1993 Associate Professor, Department of Internal Medicine

Charles R. Drew University of Medicine and Science

Compton, California

2

1982-1992 Assistant Professor, Department of Pathology

Charles R. Drew University of Medicine and Science

Compton, California

1981-1982 Adjunct Assistant Professor, Department of Surgery

Harbor/UCLA Medical Center, Torrance, California.

1977-1979 Assistant Professor and Chairman, Department of Biology

Free University of Iran

RESEARCH AND EMPLOYMENT HISTORY

1988-Present Founder, CEO and Vice President of Research and Development

at Immunosciences Lab., Inc., Los Angeles, California

Research Topics:

1. Development of Novel Techniques for the Diagnosis of

Immune Disorders.

2. The Role of Infectious Agents, Xenobiotics and Dietary

Proteins in Neuroimmune Disorders.

1986-1988 Vice President, Research and Development at

Allergy Immunotechnologies, Newport Beach,

California.

Research Topics:

1. Pancreatic Islet Cell Destruction by Cytotoxic Lymphocytes.

2. Chemical Induced Autoimmune Diseases.

3. Sensitive ELISA Assay for Helicobacter pylori

1984-1986 Director of Research and Development at Advanced Allergy

Research Center, Los Angeles, California.

Research: Development of new Enzyme Immunoassays for

Measurements of Type I, Type II, Type III and

Type IV Allergies.

1982-1984 Pathology Department, Charles Drew

Postgraduate Medical School, Compton, California.

Teaching: Immunology workshops for MARC and MBRS

students.

Research: Effects of Environmental Chemicals on Cell Mediated

Immune Function.

3

1981-1982 Surgery Department Harbor/UCLA

Medical Center, Torrance, California.

Teaching: Microbiology for 2nd year of Medical School.

Research:

1. Purification and Isolation of Histaminocytes from Rat

Gastric Mucosa.

2. Mitogenic Activity of Earthworm Coelomic Fluid.

SCIENTIFIC SOCIETY MEMBERSHIP

American Association of Immunologists

American Association for Advancement of Science

American Academy of Environmental Medicine

American Society of Microbiology

California Association for Medical Laboratory Technology

International Society for Neuroimmunology

Society of Mucosal Immunology

MEMBER OF EDITORIAL BOARDS OF PEER-REVIEWED JOURNALS

2010-Present Case Reports in Immunology

2010-Present Alternative Therapies in Health and Medicine

2009-Present Autism Insights

2006-Present European Journal of Inflammation

2003-Present Evidence-based Complementary and Alternative Medicine (eCAM)

EDITOR, PUBLISHED BOOKS AND SPECIAL ISSUES

2015 Neuroimmunity and the Brain-Gut Connection. Functional

Neurology series, Nova Science Publishers Inc., New York, 2015.

2013-2014 Autoimmune Diseases: Special Issue: Environmental Triggers and

Autoimmunity – Lead Guest Editor

4

PUBLICATIONS

1. Avtalion R.R., Ziegler R., Pearl M., Wojdani A., Sompolinsky D., Depressed resistance to

tetracycline. Staphylococcus aureus Microbios 3:165-180, 1971.

2. Avtalion R., Wojdani A., Electrophoresis and immunoelectrophoresis of sera from FI

hybrids of Tilapia. Bamidegh, Bull. Fish Cult. Isr. 28:17-24, 1971.

3. Sompolinsky D., Wojdani A., Avtalion R., The molecular basis of tetracycline resistance in

Staphylococcus aureus. In: Bacterial Plasmid and Infections Resistance (1st Int. Sym. Infect.,

Antibiotic Resistance, Smolenic, Czechoslovakia (1971), Springer Verlag, Heidelberg, p. 417-

423, 1972.

4. Avtalion R., Wojdani A., Duchyminer M., Antibody formation in carp (Cyprinus carpio),

temperature effects and mechanisms. In: Phylogenic and Ontogenic-Studies of the Immune

Response and its Contribution to the Immunological Theory. Insrm Edition, Paris, p.75-89,

1972.

5. Avtalion R., Gorlin A., Gutwirth E., Wojdani A., Determination of blood volume in fish: A

new method. Bamidegh, Bull Fish Cult. Isr. 26:16-20, 1973.

6. Avtalion R., Malik Z., Wojdani A., Shahrabani R., Duchyminer M., Influence of

environmental temperature on the immune response in fish. Curr. Top. Immunol. 61:1-35,

1973.

7. Avtalion R., Wojdani A., Pruginin V., Rothbard S., Determination of allogenic and xenogenic

markers in the genus of Tilapia. Identification of sex and hybrid by electrophoretic analysis of

serum proteins. Aquaculture 7:225-232, 1976.

8. Wojdani A., Avtalion R., Sompolinsky D., The isolation of characterization of tetracycline

resistant proteins from Staphylococcus aureus and Escherichia coli. Antimicrobial Agents

Chemother. 9:526-534, 1976.

9. Sompolinsky D., Wojdani A., Hammerman Il, Tetracycline resistance antigen from

Staphylococcus aureus. Fems Microbiol Lett. 4:23-26, 1978.

10. Cooper E.L., Stein E., Wojdani A., Lemmi C.A., and Tochinai S., Induction of earthworm

Antierythrocyte agglutinins. In: Aspects of Developmental and Comparative Immunology, 1,

pp, 17-22, J.B. Solomon (ed.), Pergamon Press, 1981.

11. Cooper E.L., Stein E., Tochinai S., Wojdani A., and Lemmi G.A., Earthworm immunity and

aging, In: Workshop on the Role of Earthworms in the Stabilization of Organic Residues.

Appelhof (compiler) Beach-Leaf Press of Kalamazoo Nature Center, Proc. Vol. 1, pp. 49-57,

1981.

5

12. Wojdani A., and Cooper E.L., Aging temperature and antibody synthesis, In: Developmental

Immunology Clinical Problem and Aging, 25, pp. 277-289, E.L. Cooper and M.A.B. Barzier

(eds.) Academic Press, 1981.

13. Stein E., Wojdani A., Cooper E.L., Agglutinins in the earthworms Lumbricus terrestris:

naturally occurring and induced. Dev. Comp. Immunol. 6:407-421,1982.

14. Wojdani A., Stein D., Lemmi C.A., Cooper E.L., Agglutinins and proteins in the

earthworm Lumbricus terrestris before and after injection of erythrocytes, carbohydrates and

other materials. Dev. Comp. Immunol. 6:613-634, 1982.

15. Wojdani A., Alfred L.J., In vivo effects of chemical carcinogens on cell-mediated immune

functions. Int. J. Immunopharmacol. 4(4):368, 1982.

16. Alfred L., Wojdani A., Effects of methylcholanthrene and benzanthracene on

blastogenesis and arylhydrocarbon hydroxylase induction in splenic lymphocytes from three

inbred strains of mice. Int. J. Immunopharmacol. 5:123-129, 1983.

17. Wojdani A., Alfred L., In vitro effects of certain polycyclic aromatic hydrocarbons on mitogen

activation of mouse T-lymphocytes: Action of histamine. Cell. Immunol. 77:132-142, 1983.

18. Alfred L., Wojdani A., Nieto M., Perez R., Yoshida G., A chemical carcinogen, 3-

methylcholanthrene alters T-cell function and induces T-suppressor cells in a mouse model

system. Immunol. 50:207-213, 1983.

19. Cooper E.L., Stein E.A. and Wojdani A., Recognition receptors in annelids. In:

Recognition Proteins, Receptors and Probes Invertebrates, E. Cohen, (ed.) Alan Liss,

New York, pp. 43-54, 1984.

20. Wojdani A., Alfred L., Alteration of cell-mediated immune functions induced in mouse

splenic lymphocyte by polycyclic achromatic hydrocarbons. Cancer Research 44:942-495,

1984.

21. Wojdani A., Stein E., Alfred L., Cooper E.L., Mitogenic effect of earthworm (Lumbricus

terrestris) coelomic fluid on mouse and human lymphocytes. Immunobiol. 166:157-167,

1984.

22. Wojdani A., Attarzadeh M., Alfred L., Immunocytotoxicity effects of polycyclic aromatic

hydrocarbons on mouse lymphocytes. Toxicol. 31:181-189, 1984.

23. Alfred L.J., Ghoneum M.H., Wojdani A., Shacks S.S., Alteration in NK activity and T-cell

subsets during the development of chemically induced tumors: role of biological response

modifiers. Immunobiol. 176:130, 1984.

6

24. Wojdani A., Etessami S., Cheung G., IgG is not the only inhibitor if IgE in the RAST test.

Ann. Allergy 55:463-468, 1985.

25. Lemmi C.A., Wojdani A., Adomian G.E., Lechago, Descanino G., Ownens-Narhi L., Two

biochemically distinct populations of histaminocytes separated by isokinetic sedimentation of

dispersed rat gastric cells. Agents and Actions 16:323-334, 1985.

26. Wojdani A., Ghoneum M., Cheung G.; Measurement of humoral and cellular immunity for the

diagnosis of Candidiasis. Clin. Ecol. 3: 201-207, 1986.

27. Ghoneum M., Wojdani A., Payne C., Suppression of basal and Corynebacterium parvum

augmented natural killer activity during chemically induced tumor development, Int. J.

Immunopharmacol. 9:71-78, 1987.

28. Wojdani A., Ghoneum M., In vivo augmentation of natural killer cell activity by Candida

albicans. Int. J. Immunopharmacol. 9:827-832, 1987.

29. Ghoneum M., Wojdani A., Alfred L., Effect of methylcholanthrene on human natural killer

cell cytotoxicity and lymphokine production in vitro. Immunopharmacol. 14:27-33, 1987.

30. Wojdani A., Thrasher J., Cheung G.P., and Heuser G., Evidence for formaldehyde

antibodies and altered cellular immunity in subjects exposed to formaldehyde in mobile

homes. Arch. of Environ. Health 42:347-351, 1987.

31. Ghoneum M., Vojdani A., Suzuki K, Gill G., Phagocytic natural killer cells. Int. J.

Immunopathol. and Pharmacol. 5:157-160, 1992.

32. Vojdani A., Ghoneum M., Brautbar N., Immune alteration associated with exposure to toxic

chemicals. Toxicology and Industrial Health 8:239-254, 1992.

33. Heuser G., Wojdani A., Heuser S., Diagnostic markers of multiple chemical sensitivity. In:

Multiple Chemical Sensitivities Addendum to Biologic Markers in Immunotoxicology.

National Academy Press, Washington D.C., pp. 117-138, 1992.

34. Heuser G., Heuser S., Rahimian P. and Vojdani A., Candida albicans and migraine

headache; A Possible Link. J. of Adv. in Med. 5:177-187, 1992.

35. Brautbar N., Vojdani A., Silicone implants and systemic immunological disease: review of the

literature and preliminary results. Toxicol. Indust. Health 8:231-238, 1992.

36. Brautbar N., Vojdani A., Campbell A.W., "Multiple chemical sensitivities: facts or myth.

Toxicol. Indust. Health Vol 8, pp. v-viii, 1992.

37. Vojdani A., Campbell A. Brautbar N., Immune functional abnormalities in patients with

clinical abnormalities and silicone breast implants. Toxicol. Indust. Health 8:415-430, 1992.

7

38. Vojdani A., Ghoneum M., In vivo effect of ascorbic acid on enhancement of human natural

killer cell activity. Nutrit. Res. 13:753-764, 1993.

39. Brautbar N., Vojdani, A., Campbell, A., Silicone breast implants and autoimmunity: causation

or myth? Arch. of Environ. Health 49:151-153, 1994.

40. Vojdani, A., Brautbar, N., Campbell, A., Laboratory tests in aid for diagnosis of silicone

induced immunological disorders: a review: Toxicol. and Indust. Health 3:1-19, 1994.

41. Campbell A.W., Brautbar N., Vojdani A., Suppressed natural killer cell activity in patients

with silicone implants: reversal upon explantation. Toxicol. And Indust. Health 10(3): 149-

154, May-June 1994.

42. Vojdani A., Brautbar N., Campbell A., Antibodies to silicone and native macromolecules in

women with silicone breast implants. Immunopharmacol. Immunotoxicol. 16:497-523, 1994.

43. Vojdani A, Brautbar N., Campbell A., Immunologic and biologic markers for silicone.

Toxicol. Indust. Health 10:25-41, 1994.

44. Brautbar N., Vojdani A., Industrial exposure to solvents and immune system dysfunction.

Hazardous Waste and Public Health, pp. 556-565, 1994.

45. Vojdani, A., Immunological studies on the blood samples of Persian Gulf War veterans and

controls. In: Persian Gulf War Illness: Are We Treating Veterans Right, a hearing before the

Committee on Veterans Affairs United States Senate U.S. Government printing office ISBN

O-16-044809-3, 115-125 Washington, 1994.

46. Brautbar N., Campbell A., and Vojdani A.; Silicone breast implants and autoimmunity:

causation, association, or myth? J. Biomaterial Science 7:133-145, 1995.

47. Vojdani A., Campbell A.W., Karjoo R., Brautbar N., Neuroimmunologic evaluation of

patients with silicone implants. Int. J. of Occup. Med. Toxicol.. 4: 25-62, 1995.

48. Vojdani A., Highlights of the Recent Immunology of Silicone Workshop, National Cancer

Institute March 13-14, 1995. Int. J. of Occup. Med. Toxicol. 4: 197-202, 1995.

49. Vojdani, A., Grimes, P., The presence of anti-benzene ring antibodies in patients with vitiligo.

Int. J. of Occup. Med. Toxicol. 5:3-10, 1996.

50. Vojdani A., Rahimian P., Kalhor H., Immunological cross-reactivity between Candida

albicans and human tissue. Clin. Lab. Immunol. 48:1-15, 1996.

51. Grimes, P., Sevall, J.S., Vojdani, A., Cytomegalovirus DNA identified in skin biopsies of

patients with vitiligo. J. Am. Acad. Dermatol. 35:21-26, 1996.

8

52. Ghoneum M., Ghonaim M., Namatalla G., Vojdani A., Alamy M., Gill G., El-Bana H., Nafie

E., ABD-El-Ghaffer Y., NK cell activity in hepatocellular carcinoma and its relation etiology

of the disease. J. Clean Technol. Environ Toxicol & Occup.Med. 5:1-18, 1996.

53. Brautbar N., Vojdani A., Immunologic and clinical aspects of silicone in women with breast

implants. In: The Augmented Breast: Radiologic and Clinical Perspective. Gorczyca D.P.,

Brenner R.J., (eds.) Thieme, New York, pp. 189-205, 1997.

54. Heuser G., Vojdani A., Enhancement of natural killer cell activity and T and B cell function

by buffered vitamin C in patients exposed to toxic chemicals: the role of protein kinase-C.

Immunopharmacol. Immunotoxicol. 19:291-312, 1997.

55. Vojdani A., Mordechai E., Brautbar N., Abnormal apoptosis and cell cycle progression in

humans exposed to methyl tertiary-butyl ether: the role of NF-kB. Human and Experimental

Toxicology 16:1-10, 1997.

56. Vojdani A., Ghoneum M., Choppa P., Minimizing cancer risk using molecular techniques: a

review. Toxicol. Indust. Health 13:589-626, 1997.

57. Vojdani A., Namatalla G., Enhancement of human natural killer cytotoxic activity by Vitamin

C in pure and augmented formulations (ultra potent-C). J. Nutrit. & Environ. Med. 7:187-195,

1997.

58. Vojdani A., Namatalla G., Brautbar N., Methy tertiary-butyl ether antibodies among gasoline

service station attendants. New York Academy of Science 837:96-103, 1997.

59. Vojdani A., Choppa P., Magtoto L., Lapp C.W. Elevated apoptotic cell population in patients

with chronic fatigue syndrome: the pivotal role of PKR. J. Internal Med. 242:465-478, 1997.

60. Ghoneum M., Namatalla G., Banionis A., Oppenheimer, La Goss N., Vojdani A., The effects

of carcinogenic methylcholathrene on carbohydrate residues of NK cell. Toxicol. Indust.

Health 13:727-741, 1997.

61. Waickman F.J., Vojdani A.; Putting chemical and environmental sensitivities in perspective.

Otolaryngologic Clinics of North America 31:55-67, 1998.

62. Vojdani A., Choppa P.C., Tagle C., Andrin R., Samimi B., Lapp C.W.; Detection of

Mycoplasma genus and Mycoplasma fermentans by PCR in patients with chronic fatigue

syndrome. FEMS Immunol. Med. Microbiol., 22:355-365, 1998.

63. Choppa P.C., Vojdani A., Multiplex PCR for Detection of Mycoplasma fermentans, M.

hominis and M. penetrans in cell cultures and blood samples of patients with chronic fatigue

syndrome. Mol. Cell. Probes 12:301-308, 1998.

64. Vojdani A., Brautbar N., Contaminated drinking water with MTBE and gasoline:

immunological and cellular effects. Eur. J. of Oncol.. 3:191-199, 1998.

9

65. Vojdani A., Choppa P.C., Lapp C.W., Downregulation of R Nase-L inhibitor correlates with

upregulation of interferon-induced proteins (2-5A Synthetase and RNase-L) in patients with

chronic fatigue and immune dysfunction syndrome. J. Clin. Lab. Immunol. 50:1-16, 1998.

66. Vojdani A., Scientific reality versus hypothesis about mycoplasma Biomedical Therapy

16(4):277-279, 1998.

67. Bartha L., Baumzweiger W., Buscher D.S., Thomas Callender, Dahl K.A., Davidoff A.,

Donnay A, Edelson S.B. Elson B.D., Elliott E., Flayhan D.P., Heuser G., Keyl P.M.,

Kilburn K. H, Gibson P, Jason L.A., Krop J., Mazlen R.D., McGill R.G., McTamney J.,

Meggs W.J, Morton W., Nass C., Oliver L.C., Panjwani D.D., Plumlee L.A., Rapp D.,

Shayevitz M.B., Sherman J., Singer R.M., Solomon A, Vodjani A., Woods J.M., Ziem

Grace; Multiple Chemical Sensitivity: A 1999 Consensus. Arch. Environ. Health.

54(3):147-149, May/Jun 1999.

68. Vojdani A., Lapp C.W., Interferon-induced proteins are elevated in blood samples of patients

with chemically or virally-induced chronic fatigue syndrome. Immunopharmacol.

Immunotoxicol. 21:175-202, 1999.

69. Vojdani A., Lapp C.W.; The relationship between chronic fatigue syndrome and chemical

exposure. J. Chronic Fatigue Syndrome 5:207-221, 1999.

70. Vojdani A., Franco A.R.; Multiplex PCR for the detection of Mycoplasma fermentans, M.

hominis and M. penetrans in patients with chronic fatigue syndrome, fibromyalgia, rheumatoid

arthritis, and Gulf War Syndrome. J. Chronic Fatigue Syndrome 5:187-197, 1999.

71. Vojdani A., Single aetiological agent may not be feasible in CFS Patients. J. Internal Med.

245:409-412, 1999.

72. Vojdani A., Immune function assessment. In: Textbook of Natural Medicine, 3rd ed. pp. 221-

239, Pizzorno J.E., Murray M.T. (eds.) Churchill Livingstone, 1999.

73. Vojdani A., Apoptosis Assessment. In: Textbook of Natural Medicine, 3rd ed. pp. 145-151,

Pizzorno J.E., Murray M.T. (eds.) Churchill Livingstone, 1999.

74. Vojdani A., Cell Signaling Analysis, In: Textbook of Natural Medicine, 3rd ed. pp. 161-163,

Pizzorno J.E., Murray M.T. (eds.) Churchill Livingstone, 1999.

75. Vojdani A., Brautbar N., White blood cell DNA adducts and immunological abnormalities in

humans exposed to contaminated drinking water containing MTBE. Eur. J. of Oncol. 4:573-

578, 1999.

76. Moss R.B., Mercadenti A., Vojdani A., TNF- and chronic fatigue syndrome. J. Clin.

Immunol. 19:314-317, 1999.

10

77. Vojdani A., Bazargan M., Wright J., Vojdani E., New evidence for anti-oxidant properties of

vitamin C. Cancer Detection and Prevention 24:508-523, 2000.

78. Vojdani A. The role of periodontal disease and other infections in the pathogenesis of

atherosclerosis and systemic diseases. Townsend Letter for Doctors and Patients. 209:52-56,

2000.

79. Rosenbaum M., Vojdani A., Susser M., Watson C.M., Improved immune activation markers

in chronic fatigue and immune dysfunction syndrome (CFIDS) patients treated with thymic

protein A. J. Nutrit. Environ. Med. 11:241-247, 2001.

80. Block K.I., Boyd D.B., Gonzalez N., Vojdani A., The immune system in cancer. Integrative

Cancer Therapies 1(3): 294-316, 2002.

81. Vojdani A., Campbell A., Anyanwu E., Kashanian A., Bock K., Vojdani E., Antibodies to

neuron-specific antigens in children with autism: possible cross-reaction with encephalitogenic

proteins from milk, Chlamydia pneumoniae and Streptococcus Group A. J. Neuroimmunol.

129:168-177, 2002.

82. Bishara J., Pitlik S., Kazakov A., Saharg G., Haddad M., Vojdani A., Rosenberg S., Samra Z.,

Failure to detect Chlamydia pneumonia by cell culture and PCR in major arteries of 93

patients with atherosclerosis. Eur. J. Clin. Infect. Dis. 22:300-302, 2003.

83. Vojdani A., Vojdani E., Cooper E.L., Antibodies to myelin basic protein, myelin

oligodendrocytes peptides, --crystallin, lymphocyte activation and cytokine production

in patients with multiple sclerosis. J. Internal Med. 254:363-374, 2003.

84. Vojdani A., Pangborn J.B., Vojdani E., Cooper E.L., Infections, toxic chemicals and dietary

peptides binding to lymphocyte receptors and tissue enzymes are major instigators of

autoimmunity in autism. Int. J. Immunopathol. Pharmacol. 16(3):189-199, 2003.

85. Vojdani A., Kashanian A., Vojdani E., Campbell A., Saliva secretory IgA antibodies

against molds and mycotoxins in patients exposed to toxigenic fungi. Immunopharmacol.

Immunotoxicol. 25:595-614, 2003

86. Anyanwu E.C., Campbell A.W., Vojdani A., Neurophysiological effects of chronic indoor

environmental toxic mold exposure on children. The Scientific World Journal 3:281-290,

2003.

87. Campbell A.W., Anyanwu E.C., Vojdani A., Combination of high-dose intravenous

immunoglobulins and itraconozole in treating chronic mycotic demyelinating optic neuritis.

The Scientific World Journal 3:640-646, 2003.

88. Vojdani A. A Look at Infectious Agents as a Possible Causative Factor in Cardiovascular

Disease: Part I. Lab Med 34(3):7-11, March 2003.

11


Disease: Part II. Lab Med 34(4):5-9, April 2003.


Disease: Part III. Lab Med 34(5):24-31, May 2003.

91. Vojdani A., Campbell A., Kashanian A., Vojdani E., Antibodies against molds and

mycotoxins following exposure to toxigenic fungi in a water-damaged building. Arch.

Environ. Health 58(6):324-336, 2003.

92. Vojdani A., Thrasher J.D., Madison R.A., Gray M.R., Heuser G., Campbell A.W., Antibodies

to molds and satratoxin in individuals exposed in water-damaged buildings. Arch. Environ.

Health 58(7)421-432, 2003.

93. Gray M.R., Thrasher J.D., Crago R., Madison R.A., Arnold L., Campbell A., Vojdani A.

Mixed mold mycotoxicosis: Immunological changes in humans following exposure to

water-damaged buildings. Arch. Environ. Health 58(7):410-420, July 2003.

94. Campbell A.W., Thrasher J.D., Madison R.A., Vojdani A., Gray M.R., Johnson A. Neural

autoantibodies and neurophysiologic abnormalities in patients exposed to molds in water-

damaged buildings. Arch. Environ. Health 58(8):464-474, August 2003.

95. Vojdani A., Bazargan M., Vojdani E., Samadi J., Nourian A.A., Eghbalieh N., Cooper E.L.,

Heat shock protein and gliadin peptide promote development of peptidase antibodies in

children with autism and patients with autoimmune disease. Clin. Diag. Lab. Immunol

11(3):515-524, May 2004.

96. Vojdani A., Cross-reactivity of Aspergillus, Penicillium, and Stachybotrys antigens using

affinity-purified antibodies and immunoassay. Arch. Environ. Health, 59(5):256-265, May

2004.

97. Vojdani A., Thrasher J.D., Cellular and humoral immune abnormalities in Gulf War veterans.

Environmental Health Perspectives 112(8):840-846, June 2004.

98. Vojdani A., O’Bryan T., Green J.A., McCandless J., Woeller K.N., Vojdani E., Nourian

A.A., Cooper E.L. Immune response to dietary proteins, gliadin and cerebellar peptides in

children with autism. Nutritional Neuroscience 7(3):151-161, June 2004.

99. Brasel T.L., Campbell A.W., Demers R.E., Ferguson B.S., Fink J., Vojdani A., Wilson

S.C., Straus D.C. Detection of trichothecene mycotoxins in sera from individuals exposed

to Stachybotrys chartarum in indoor environments. Archives of Environmental Health,

59(6):317-323, June 2004.

100. Campbell A.W., Thrasher J.D., Gray M.R., Vojdani A., Molds and mycotoxins: effects on the

neurological and immune system in humans. In: Sick Building Syndrome, 55, pp. 375-398, D.

C. Straus (ed.), Academic Press/Elsevier, August 2004.

12

101. Vojdani A., Cooper E.L. Identification of diseases that may be targets for complementary

and alternative medicine (CAM). In: Complementary and Alternative Approaches to

Biomedicine, pp. 75-104, E. L. Cooper and N. Yamaguchi (eds.), Kluwer

Academic/Plenum Publishers, 2004.

102. Vojdani A., Antibodies against Stachybotrys chartarum extract and its antigenic

components, Stachyhemolysin and Stachyrase-A: A new clinical bio-marker. Medical

Science Monitor, 11(5):139-145, 2005.

103. Vojdani A., Cooper E.L., Antibodies against central nervous system antigens in autism:

possible cross-reaction with dietary proteins and infectious agent antigens.

Neuropsychiatric Disorders and Infection, pp. 171-186, S.H. Fatemi (ed.), Taylor &

Francis Ltd., London, 2005.

104. Vojdani A., Erde J., Regulatory T cells, a potent immunoregulatory target for CAM

researchers: the ultimate antagonist (I). eCAM. 3(1):25-30, Mar 2006

105. Vojdani A., Erde J., Regulatory T cells, a potent immunoregulatory target for CAM

researchers: Modulating allergic and infectious disease pathology (II). eCAM.; 3(2):209–

215, 2006.

106. Vojdani A, Erde J. Regulatory T cells, a potent immunoregulatory target for CAM

researchers: Modulating tumor immunity, autoimmunity and alloreactive immunity (III).

eCAM; 3(3):309-316, 2006.

107. Roby R.R., Richardson R.H., Vojdani A., Hormone Allergy, Amer J Reprod Immunol,

55:307-313, 2006.

108. Burazor I., Vojdani A., Bogdanović D. Porhyromonas gingivalis and acute myocardial

infarction. Acta Fac Med Naiss, 23(2):69-74, 2006.

109. Vojdani A., Raxlen B., Scott S. In vivo-induced antigen technology: the most sensitive

method of detection for Lyme disease and other tick-borne diseases. Townsend Letter,

April:107-113, 2007.

110. Vojdani A., Raxlen B., Scott S. The use of lymphocyte proliferation assay and cytokine

production in seronegative patients with Lyme arthritis or neuroborreliosis. Townsend

Letter, May:104-111, 2007.

111. Burazor I., Vojdani A., Burazor M. Failure to detect Chlamydia pneumoniae by polymerase

chain reaction in acute coronary syndromes. In New horizons in coronary artery disease,

pp. 123-126, Lewis B., Halon D., and Flugelman M. (eds), Medimond Publishing Co-

Bologna, Italy, 2007.

13

112. Vojdani A. Obsessive compulsive disorder and differentiation between non-autoimmune

OCD and the autoimmune version of the disease called PANDAS. Latitudes; 6(2), 2007.

113. Vojdani A, Kellermann GH, Bush BJ. The case for clinical neuroimmunology. Townsend

Letter, 294: 68-70, 2008.

114. Burazor I., Vojdani A., Burazor M. Interrelationship of interleukin 6, C-reactive protein and

Chlamydiae pneumoniae IgG antibodies in patients with acute coronary syndromes.

Vojnosanit Pregled, 65(6):425-434, 2008.

115. Vojdani A, O’Bryan T, Kellermann GH. The immunology of immediate and delayed

hypersensitivity reaction to gluten. European Journal of Inflammation; 6(1):1-10, 2008.

116. Vojdani A, O’Bryan T, Kellermann GH. The immunology of gluten sensitivity beyond the

intestinal tract. European Journal of Inflammation; 6(2):49-57, 2008.

117. Vojdani A. Antibodies as predictors of autoimmune diseases and cancer. Expert Opinion

on Medical Diagnostics; 2(6):593-605, 2008.

118. Vojdani A. Antibodies as predictors of complex autoimmune diseases. International

Journal of Immunopathology and Pharmacology; 21(2):267-278, 2008.

119. Vojdani A. Antibodies as predictors of complex autoimmune diseases and cancer.

International Journal of Immunopathology and Pharmacology; 21(3):553-566, 2008.

120. Vojdani A, Mumper E, Granpeesheh D, Mielke L, Traver D, Bock K, Hirani K, Neubrander

J, Woeller KN, O'Hara N, Usman A, Schneider C, Hebroni F, Berookhim J, McCandless J.

Low natural killer cell cytotoxic activity in autism: the role of glutathione, IL-2 and IL-15.

Journal of Neuroimmunology; 205:148-154, 2008.

121. Vojdani A., Hebroni F., Raphael Y., Erde J., Raxlen B. Novel diagnosis of Lyme disease:

potential for CAM intervention. eCAM, 2009 6(3):283-295.

122. Vojdani A, Lambert J. A gut feeling for immune dysregulation and neuroinflammation in

autism. The Autism File; 31:56-64, 2009.

123. Vojdani A, Lambert J. The role of Th17 in neuroimmune disorders: target for CAM therapy

I. eCAM; eCAM advance access July 21, 2009, doi:10.1093/ecam/nep062.

124. Vojdani A, Lambert J. The role of Th17 in neuroimmune disorders: target for CAM therapy

II. eCAM; eCAM advance access July 21, 2009, doi:10.1093/ecam/nep063.

125. Vojdani A, Lambert J, Kellermann G. The role of Th17 in neuroimmune disorders: target

for CAM therapy III. eCAM; eCAM advance access July 21, 2009,

doi:10.1093/ecam/nep064.

14

126. Vojdani A. Detection of IgE, IgG, IgA and IgM antibodies against raw and processed food

antigens. Nutrition and Metabolism; 6:(22), 2009.

127. Kawikova I, Grady BXY, Zhang Y, Vojdani A, Katsovitch L, Richmond BJ, Par TW,

Bothwell ALM, Leckman JF. Children with Tourette’s syndrome may suffer from IgA

dysgammaglobulinemia: preliminary report. Biological Psychiatry; 67:679–683, 2010.

128. Vojdani A, Lambert J. Functional neurology and immunology: I. The immunology of the

mind-body connection. Functional Neurology, Rehabilitation, and Ergonomics, 1(2):

207-221, 2011.

129. Vojdani A, Lambert J. Functional neurology and immunology: II. The immune system,

mucosal immunity and intestinal permeability. Functional Neurology, Rehabilitation, and

Ergonomics, 1(2): 223-236, 2011.

130. Vojdani A. The characterization of the repertoire of wheat antigens and peptides involved

in the humoral immune responses in patients with gluten sensitivity and Crohn’s disease.

ISRN Allergy; 2011, doi:10.5402/2011/950104, 1-12.

131. Vojdani A, Lambert J. Functional neurology and immunology: III. Cell-mediated

immunity. Functional Neurology, Rehabilitation, and Ergonomics, 1(3): 443-460, 2011.

132. Vojdani A, Lambert J. Functional neurology and immunology: IV. Natural killer, T-cell

and B-cell function in health and disease. Functional Neurology, Rehabilitation, and

Ergonomics, 1(3): 461-483, 2011.

133. Vojdani A, Lambert J. Functional neurology and immunology: V. Crossing barriers: gut-to-

brain lessons from interdisciplinary collaboration. Functional Neurology, Rehabilitation,

and Ergonomics, 1(4): 615-630, 2011.

134. Vojdani A, Lambert J. Functional neurology and immunology: VI. Neuroautoimmunity:

origins, mechanisms, assessments. Functional Neurology, Rehabilitation, and

Ergonomics, 1(4): 631-644, 2011.

135. Vojdani A, Bautista J. Intestinal and blood-brain barrier: Interface between health and

diseases. Functional Neurology, Rehabilitation, and Ergonomics, 2(3): 277-297, 2012.

136. Vojdani A, Lambert J. The onset of enhanced intestinal permeability and food sensitivity

triggered by medication used in dental procedures: A case report. Case Reports in

Gastrointestinal Medicine, 2012; doi: 1155/2012/265052. Epub 2012 Sep 12.

137. Vojdani A. For the assessment of intestinal permeability, size matters. Alternative

Therapies in Health and Medicine, 19(1):12-24, 2013.

138. Vojdani A. Interview with Burnett K. Environmental factors and autoimmune disease.

Alternative Therapies in Health and Medicine, 19(1):70-75, 2013.

15

139. Vojdani A. Enhanced testing for gluten and food sensitivity. Townsend Letter, 354:56-63,

2013.

140. Vojdani A, Tarash I. Cross-reaction between gliadin and different food and tissue antigens.

Food and Nutrition Sciences, 44:20-32, 2013.

141. Perlmutter D, Vojdani A. Association between headache and sensitivities to gluten and

dairy. Integrative Medicine, 12(2):39-44, 2013.

142. Vojdani A, Perlmutter D. Differentiation between celiac disease, non-celiac gluten

sensitivity, and their overlapping with Crohn’s disease: a case series. Case Reports in

Immunology, 2013, dx.doi.org/10.1155/2013/248482.

143. Vojdani A. Celiac disease and its association with other autoimmune disorders beyond the

gut. Townsend Letter, June 2013.

144. Vojdani A. Metabolic diseases driven by immunoinflammation. Functional Neurology,

Rehabilitation, and Ergonomics, 3(2-3):149-171, 2013.

145. Vojdani A. Brain-reactive antibodies in traumatic brain injury. Functional Neurology,

Rehabilitation, and Ergonomics, 3(2-3):173-181, 2013.

146. Vojdani A, Lambert J. The role of environmental triggers in neuroautoimunity. Functional

Neurology, Rehabilitation, and Ergonomics, 3(2-3):183-202, 2013.

147. Vojdani A, Kharrazian D, Mukherjee PS. The prevalence of antibodies against wheat and

milk proteins in blood donors and their contribution to neuroautoimune reactivities.

Nutrients, 6:15-36, 2014, doi:10.3390/nu6010015.

148. Vojdani A. A potential link between environmental triggers and autoimmunity.

Autoimmune Diseases, Volume 2014, Article ID 437231, 18 pages.

http://dx.doi.org/10.1155/2014/437231, 2014.

149. Burazor I, Vojdani A. Chronic exposure to oral pathogens and autoimmune reactivity in

acute coronary thrombosis. Autoimmune Diseases, Volume 2014, Article ID 613157, 8

pages. http://dx.doi.org/10.1155/2014/613157, 2014.

150. Burazor I., Vojdani A. Infectious agents and autoimmunity in acute coronary

atherothrombosis. In Opportunistic infections: Pathology, prevention and treatment, Nova

Science Publishers, Hauppage, NY, 2014.

151. Vojdani A. Food immune reactivity and neuroautoimmunity. Funct Neurol Rehabil Ergon,

4(2-3):175-195, 2014.

16

152. Vojdani A. Blood-brain barrier damage and neuroautoimmunity. Townsend Letter, 58-64,

October 2014.

153. Calderón-Garcidueñas L., Vojdani A., Blaurock-Busch E., Busch Y., Friedle A., Franco-

Lira M., Sarathi-Mukherjee P., Park S.-B., Torres-Jardón R., D’Angiulli A. Air pollution

and children: Neural and tight junction antibodies and combustion metals, the role of barrier

breakdown, and brain immunity in neurodegeneration. Journal of Alzheimer’s Disease,

43(3):1039-1058, 2015. doi: 10.3233/JAD-141365

154. Calderón-Garcidueñas L, Gónzalez-Maciel A, Vojdani A, Franco-Lira M, Reynoso-Robles

R, Montesinos-Correa H, Pérez-Guillé B, Mukherjee PS, Torres-Jardón R, Calderón-

Garcidueñas A and Perry G. The intestinal barrier in air pollution-associated neural

involvement in Mexico City residents: mind the gut, the evolution of a changing paradigm

relevant to Parkinson disease risk. J Alzheimers Dis Parkinsonism, 5(1), 2015,

http://dx.doi.org/10.4172/2161-0460.1000179.

155. Vojdani A, Kharrazian D, Mukherjee PS. Elevated levels of antibodies against xenobiotics

in a subgroup of healthy subjects. Journal of Applied Toxicology, 35(4): 383-397, 2015.

156. Vojdani A. The evolution of food immune reactivity testing: Why food IgG or IgA

antibody may not be reproducible from one lab to another, and sometimes not even in the

same laboratory. Alternative Therapies in Health and Medicine, 21(Suppl 1): 8-22, 2015.

157. Vojdani A. Oral tolerance and its relationship to food immunoreactivities. Alternative

Therapies in Health and Medicine, 21(Suppl 1): 23-32, 2015.

158. Vojdani A. Molecular mimicry as a mechanism for food immune reactivity and

autoimmunity. Alternative Therapies in Health and Medicine, 21(Suppl 1): 34-45, 2015.

159. Vojdani A. Lectins, agglutinins, and their role in autoimmune reactivities. Alternative


160. Vojdani A, Vojdani C. Immune reactivity to food coloring. Alternative Therapies in

Health and Medicine, 21(Suppl 1): 52-62, 2015.

161. Vojdani A, Vojdani C. Immune reactivities against gums. Alternative Therapies in Health

and Medicine, 21(Suppl 1): 64-72, 2015.

162. Vojdani A. Immune reactivities to peanut proteins, agglutinins and oleosins. Alternative


163. Vojdani A, Mukherjee PS, Berookhim J, Kharrazian D. Detection of antibodies against

human and plant aquaporins in patients with multiple sclerosis. Autoimmune Diseases,

Volume 2015, Article ID 905208, 10 pages, http://dx.doi.org/10.1155/2015/905208, 2015.

17

164. Vojdani A. Reaction of monoclonal and polyclonal antibodies made against infectious

agents with various food antigens. J Clin Cell Immunol, 6:5, 2015,

http://dx.doi.org/10.4172/2155-9899.1000359.

165. Kharrazian D, Vojdani A. Correlation between antibodies to bisphenol A, its target enzyme

protein disulfide isomerase and antibodies to neuron-specific antigens. J Appl Toxicol,

2016 Sep 9. doi: 10.1002/jat.3383. Epub 2016 Sep 9.

166. Vojdani A, Vojdani E. Gluten and non-gluten proteins of wheat as target antigens in autism,

Crohn’s and celiac disease. J Cereal Science, 75: 252-260, 2017.

167. Kharrazian D, Herbert M, Vojdani A. Detection of islet cell immune reactivity with low

glycemic index foods – Is this a concern for type 1 diabetes? J Diabetes Res, Volume 2017,

Article ID 4124967, doi.org/10.1155/2017/4124967.

168. Vojdani A, Vojdani E, Kharrazian D. Fluctuation of zonulin levels in blood versus stability

of antibodies. World J Gastroenterol, 23(31): 5669-5679, 2017, doi:

10.3748/wjg.v23.i31.5669

169. Kharrazian D, Herbert M, Vojdani A. Immunological reactivity using monoclonal and

polyclonal antibodies of autoimmune thyroid target sites with dietary proteins. J Thyroid

Res, Vol. 2017, Article ID 4354723, doi.org/10.1155/2017/4354723.

170. Lambert J, Vojdani A. Correlation of tissue antibodies and food immune reactivity in

randomly selected patient specimens. J Clin Cell Immunol, 8(5): 521, 2017, DOI:

10.4172/2155-9899.1000521

171. Vojdani A, Lambert J, Vojdani E. Blood-based markers in autism spectrum disorders: Part

1. The mechanisms of dysregulation. Internal Medicine Review, 3(11), 2017

172. Vojdani A, Lambert J, Vojdani E. Blood-based markers in autism spectrum disorders: Part

2. Clinical lab biomarkers. Internal Medicine Review, 3(11), 2017

173. Vojdani A, Vojdani E, Saidara E, Kharrazian D (2018) Reaction of amyloid-β peptide

antibody with different infectious agents involved in Alzheimer’s disease. J Alzheimers

Dis, 63(2018): 847-860 doi:10.3233/JAD-170961

174. Vojdani A, Vojdani E (2018) Amyloid-β 1-42 cross-reactive antibody prevalent in human

sera may contribute to intraneuronal deposition of AβP-42. Int J Alzheimers Dis Volume

2018, Article ID 1672568, 12 pages doi:10.1155/2018/1672568

175. Vojdani A, Vojdani E (2018) Immunoreactivity of Anti-AβP-42 specific antibody with

toxic chemicals and food antigens. J Alzheimers Dis Parkinsonism 8:3 doi:10.4172/2161-

0460.1000441

http://dx.doi.org/10.4172/2155-9899.1000359

18

176. Vojdani A, Turnpaugh C, Vojdani E (2018) Immune reactivity against a variety of

mammalian and plant-based milks. J Dairy Research (In Press)

177. Vojdani A, Lambert J, Salazar C, Kharrazian D (2018) Correlation of intestinal bacterial lipopolysaccharide antibodies and blood-brain barrier antibodies in IBD subjects. J Clin Rev Allergy Immunol (Submitted)

178. Lambert J, Mejia S, Vojdani A (2018) Plant and human aquaporins: Pathogenesis from gut to brain. J Clin Rev Allergy Immunol (Submitted)

179. Vojdani A, Vojdani E, Vojdani C (2018) The immune system: Our body’s homeland

security against disease. In “Integrative and Functional Medical Nutrition Therapy:

Principles and Practices.” Eds. Noland D, Drisko JA. Springer Publications (In Press)

180. Vojdani A, Vojdani E, Vojdani C (2018) The immune system: Our body’s homeland

security against disease. In “Integrative and Functional Medical Nutrition Therapy:

Principles and Practices.” Eds. Noland D, Drisko JA. Springer Publications (In Press)

AWARDS AND HONORS

On October 27, 2012, Dr. Vojdani was given the distinguished F. R. Carrick Research Institute

Lifetime Achievement Award by the International Association of Functional Neurology and

Rehabilitation.

On November 7, 2009, Dr. Vojdani was given the Linus Pauling Award by the American

College for Advancement in Medicine.

In 2006, Dr. Vojdani was given the prestigious Herbert J. Rinkel Award by the American

Academy of Environmental Medicine (AAEM) for excellence in teaching the techniques of

environmental medicine.

1999 Award by the Department of Veterans Affairs, Veterans Health Administration’s Office of

Research and Development, Washington D.C. to conduct a study on whether a one-year treatment

of doxycycline administered to patients with Gulf War illness who are mycoplasma positive, can

improve functional status in comparison to similar patients treated with a placebo.

NIH National Institute of Allergy and Infectious Diseases between 9/30/90 - 3/31/91. Phase I study

of binding allergens to liposomes for immunotherapy.

NIH MBRS Grant Award between 1982-1985 on the effects of environmental chemicals on cell

mediated immune functions. Principal investigator with Dr. Lawrence Alfred.

Recipient of the Scientific Presentation Award: American Academy of Otolaryngic Allergy, 1984.

Environmental Protection Agency Grant Award between 1981-1983 on human lymphocyte

responses to carcinogenic chemicals. Co-investigator with Dr. Lawrence Alfred.

19

Testimony in the U.S Senate:

Dr. Vojdani appeared before the US Senate Committee on Veterans Affairs on November 16, 1993

to provide testimony relative to immunological studies on blood samples of Persian Gulf War

veterans and controls. His findings indicated that some of the veterans who had been exposed to

chemical agents while serving in that war had neuroimmunological disorders. This testimony was

instrumental in winning the passage of a law, initiated by Chairman of the Senate Committee on

Veterans Affairs, Senator J. D. Rockefeller on November 22, 1993 that would provide free medical

care to Persian Gulf War veterans.

PATENTS

1. Vojdani, Aristo - United States Patent #4,946,945 was approved on the subject of

“Immunotherapy agents for treatment of IgE mediated allergies.” Date of approval: August 7,

1990.

2. Vojdani, Aristo - United States Patent #5,707,816 was approved on the subject of

“Immunological cross-reactivity between candida and human tissue or food antigen.” Date of

approval: January 13, 1998.

3. Vojdani, Aristo - United States Patent #5,766,859 approved on the subject of “Ribonuclease L-

inhibitor as an indicator of chronic fatigue syndrome.” Date of approval: June 16, 1998.

4. Vojdani, Aristo - United States Patent #5,766,69 approved on the subject of “Detection of

chronic fatigue syndrome.” Date of approval: July 7, 1998.


chronic fatigue syndrome.” Date of approval: November 3, 1998.


chronic fatigue syndrome by increased apoptosis and cell cycle arrest of PBMC’s.” Date of

approval: December 29, 1998.

7. Vojdani, Aristo - United States Patent #6,020,205 approved on the subject of “Determination of

intracellular antioxidant levels.” Date of approval: February 1, 2000.

8. Vojdani, Aristo - United States Patent #6,103,480 approved on the subject of “Single blood test

for determination of food allergy, candidiasis, microflora imbalance, intestinal barrier

dysfunction and humoral immunodeficiencies.” Date of approval: August 15, 2000.

9. Vojdani, Aristo - United States Patent #6,492,113 B1 approved on the subject of “Detection of

mycoplasma genus and species in patients with chronic fatigue syndrome and fibromyalgia.”

Date of approval: December 10, 2002.

10. Vojdani, Aristo - United States Patent #6,689,569 approved on the subject of a saliva test for

“Detection of food allergy, candidiasis, microflora imbalance, intestinal barrier dysfunction and

humoral immunodeficiencies.” Date of approval: October 2003.

20

11. Vojdani, Aristo – United States Patent #2003/0143627 A1 approved on the subject of “Saliva

test for detection of food allergy and intolerance.” Date of approval: July 31, 2003.

12. Vojdani, Aristo – United States Patent #7,252,957 B2 approved on the subject of “Identification

in the etiology of autism.” Date of approval: August 7, 2007.

13. Vojdani, Aristo – United States Patent #7,258,994 B2 approved on the subject of “Saliva

immunoassay for detection of antibodies for cardiovascular disease.” Date of approval: August

21, 2007.

14. Vojdani, Aristo – United States Patent #7,390,626 approved on the subject of “Methods and kit

for diagnosing tick borne illnesses.” Date of approval: June 24, 2008.

15. Vojdani, Aristo – United States Patent Pub. #8,663,911 B2 on the subject of “Method for

detection of intestinal, and blood-brain barrier permeability and testing materials thereto.” Date

of approval: March 4, 2014.

16. Vojdani, Aristo – United States Patent Application #13/354,119on the subject of “Methods and

apparatus for detection of gluten sensitivity, and its differentiation from celiac disease.”

Submitted on January 19, 2012.

CURRICULUM VITAE - Your Medical DetectiveCURRICULUM VITAE Aristo W/Vojdani, Ph.D., M.Sc., C.L.S....

Documents

Transcript of CURRICULUM VITAE - Your Medical DetectiveCURRICULUM VITAE Aristo W/Vojdani, Ph.D., M.Sc., C.L.S....